Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Breast Radiology

When Should I Get a Second Opinion for Breast Fibrosis?

At a Glance

You may not need a routine second opinion after a breast fibrosis biopsy if the sample was adequate, the result explains the imaging, and follow-up is clear. Seek expert review for a mismatch, atypical findings, a missed target, or changing symptoms, without delaying care.

Getting a second opinion on a breast biopsy or mammogram can be a valuable step, but it is not necessary for everyone. Hearing the word “benign” (non-cancerous) can bring relief, but if your doctor recommends further testing, it can also cause anxiety. The goal of a second opinion is to ensure that your clinical exams, imaging, and biopsy results all tell one consistent story. If your biopsy was adequately sampled, the finding of breast fibrosis completely explains the abnormality seen on your imaging, and your care team has a consistent follow-up plan, a routine external second opinion is often unnecessary [1]. However, you should consider seeking an expert review if your imaging and biopsy results do not match (discordance), if the pathologist finds “atypia” or other borderline features, if the biopsy missed the targeted area, or if you have a persistent or changing physical symptom [2][3][4].

1. The Key Concept: Are Your Results “Concordant”?

The most critical factor after a benign biopsy is whether your results are radiologic-pathologic concordant [5]. Concordance means that the benign tissue removed during the biopsy logically explains the abnormality seen on your imaging [1].

Discordance happens when they do not match [6]. For example, if your mammogram showed highly suspicious calcifications (often categorized as BI-RADS 4, meaning suspicious, or BI-RADS 5, meaning highly suggestive of malignancy), but the biopsy only found breast fibrosis and no calcifications, the results are discordant [7][8].

A benign biopsy result is not reassuring if it does not explain the imaging [1]. In discordant cases, standard medical guidelines recommend a multidisciplinary review—where breast radiologists and pathologists discuss your case together—and often require a repeat biopsy or surgical excision to ensure nothing was missed [9][10][2].

2. When to Consider a Pathology (Biopsy) Second Opinion

If your biopsy tissue requires a closer look, you might benefit from a breast pathologist reviewing your slides. This is especially helpful in these situations:

  • Atypia (High-Risk Changes): If your biopsy shows atypical ductal hyperplasia (ADH), expert review is often valuable [11]. ADH is a non-cancerous, higher-risk lesion, but it can be very difficult to distinguish from non-invasive cancer (DCIS) under a microscope [12].
  • Complex or Borderline Lesions: Certain findings, such as papillary lesions, radial scars, or fibroepithelial lesions, can be challenging to classify from a small core biopsy sample [13][3]. For instance, distinguishing between a benign fibroadenoma and a phyllodes tumor sometimes requires specialist review to determine if the lesion needs to be surgically removed [14].

3. Was the Right Area Sampled? (Targeting)

Sometimes the issue is not how the pathologist read the slides, but whether the biopsy needle captured the right tissue [8]. If your pathology report notes that the sample was “limited” or if the biopsy clip appears to have migrated from the target area, ask your breast radiologist to review the post-biopsy images and procedure notes [8]. If the suspicious target was not adequately sampled, a repeat biopsy or surgical excision—rather than just a pathology slide reread—may be necessary [2].

4. When to Consider an Imaging Second Opinion (or Repeat Clinical Exam)

A sub-specialized breast radiologist can provide a second read of your mammogram, ultrasound, or MRI if the original findings were subtle, ambiguous, or technically limited [15]. However, imaging second opinions must be handled carefully to avoid delaying necessary care:

  • Palpable Lumps with Normal Imaging: If you have a persistent or clinically suspicious lump but your mammogram and ultrasound are normal, do not assume you are in the clear or simply wait for a second imaging read. Normal imaging does not completely rule out cancer [4]. A concerning symptom still requires prompt clinical evaluation and potentially a tissue biopsy [16].
  • Changing Lesions: If a breast lump was previously graded as “probably benign” (BI-RADS 3) but has grown or changed shape, this warrants a timely reassessment by your treating breast-imaging team—which may prompt a biopsy [17][18]. Do not wait for an outside second opinion; contact your current team promptly.

5. How to Gather Records for a Second Opinion

When seeking a second opinion, it is helpful to provide the complete picture. Usually, the reviewing center will tell you what they need and how to request it. A typical checklist includes [19][20]:

  • Pathology and procedure reports from your original biopsy.
  • Imaging reports for your most recent mammogram, ultrasound, or MRI.
  • Original imaging files, including prior images for comparison and the post-biopsy “specimen radiograph” (if calcifications were biopsied) [21][8]. These are often transferred electronically or on a disc.
  • Pathology slides or tissue blocks. You usually sign a release form, and the new center or your original hospital will coordinate sending the physical glass slides or paraffin blocks directly between the laboratories [13].
  • Clinical context: Ensure the reviewing team knows your personal and family breast cancer history [22].

A Crucial Precaution: Do Not Delay Urgent Care

While a second opinion is a powerful tool for ensuring accurate diagnosis, the process of gathering records can take weeks. Do not delay prompt clinical evaluation of a changing lesion [23]. If you develop a new or worsening mass, skin tethering (dimpling), or spontaneous, persistent, bloody, or clear single-duct nipple discharge, keep your current diagnostic appointments [23]. Diagnostic delays can negatively impact health outcomes, so pursue any needed second opinion in parallel with the urgent follow-up care recommended by your doctor [24][25].

Common questions in this guide

Do I always need a second opinion after a breast fibrosis biopsy?
No. If the biopsy sampled the right area, the breast fibrosis fully explains the imaging finding, and your clinicians agree on follow-up, an outside review may not be needed. A second opinion is more important when the results do not match, atypical features are present, the target may have been missed, or symptoms persist or change.
What does it mean if my biopsy and mammogram do not match?
This is called discordance: the benign tissue found by biopsy does not adequately explain the abnormality on imaging. For example, suspicious calcifications on a mammogram with a sample showing fibrosis but no calcifications may need review by breast radiology and pathology, followed by a repeat biopsy or surgical removal if recommended.
When should a breast pathologist review my biopsy slides?
A specialist review may help when a report mentions atypical ductal hyperplasia, a papillary lesion, a radial scar, or a fibroepithelial lesion. These findings can be difficult to classify from a small needle sample and may affect whether surgery is recommended.
Can a normal mammogram rule out cancer if I can feel a lump?
No. A normal mammogram and ultrasound do not completely explain away a persistent or clinically concerning lump. Contact your treating clinician promptly; you may need a repeat examination or tissue biopsy rather than waiting for an outside imaging read.
What should I send for a breast biopsy or mammogram second opinion?
Provide biopsy and procedure reports, imaging reports, original mammogram, ultrasound, or MRI files, prior images, and any post-biopsy specimen images. The reviewing center may also request pathology slides or tissue blocks and your personal and family breast cancer history.
Should I wait for a second opinion if my breast lump or nipple discharge is changing?
No. Keep recommended diagnostic appointments and contact your current care team promptly for a new or worsening lump, skin dimpling, or spontaneous persistent bloody or clear discharge from one duct. You can pursue an outside review at the same time, but record collection should not delay urgent evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my biopsy result completely 'concordant' with my imaging findings?
  2. 2.Do the pathology findings (like breast fibrosis) logically and fully explain the abnormality seen on my mammogram or ultrasound?
  3. 3.Did the post-biopsy images or specimen radiographs confirm that the biopsy needle actually sampled the most suspicious area?
  4. 4.Does my biopsy show any 'atypia', papillary lesions, or other complex features that might benefit from an expert breast pathologist's review?
  5. 5.If my palpable lump is changing but my mammogram is normal, what is our next clinical step?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can a Needle Biopsy Worsen Breast Fibrosis or Spread a Lump?Can Benign Breast Fibrosis Cause Lumps in Both Breasts?Does Breast Fibrosis Affect Pregnancy or Breastfeeding?Can Breast Fibrosis Cause Breast Pain Like Breast Cancer?Can Dense Breasts Make Breast Fibrosis Harder to See?Does a Breast Biopsy Marker Clip Stay in Permanently?Does Benign Breast Fibrosis Increase Breast Cancer Risk?Does Breast Fibrosis Go Away? What to Expect Over TimeHow Accurate Is a Benign Breast Biopsy Showing Fibrosis?What Causes Breast Fibrosis Without Radiation Treatment?What Does Idiopathic Stromal Fibrosis Mean on Breast Biopsy?Benign Breast Fibrosis Biopsy: What Follow-Up Is Needed?Why Is Breast Imaging Suspicious After a Benign Biopsy?Core or Vacuum-Assisted Biopsy for Breast Fibrosis?How Does Breast Scar Tissue Differ From Radiation Fibrosis?What Should a Breast Fibrosis Biopsy Report Include?Breast Fibrosis Lump After Biopsy: What Should I Do?When Is Breast MRI Recommended for Breast Fibrosis?When Does Breast Fibrosis Need Repeat Biopsy or Surgery?

References

References (25)
  1. 1

    Institutional Review of BI-RADS 5 and BI-RADS 4C Lesions Over 5 Years Following Surgical Excision: Analysis of Radiology-Pathology Correlation.

    Brodsky JE, Ly M, Jang S, et al.

    Journal of breast imaging 2026; (8(5)):540-549 doi:10.1093/jbi/wbag019.

    PMID: 42479170
  2. 2

    Radiologic-Pathologic Discordance and Outcome After MRI-Guided Vacuum-Assisted Biopsy.

    Lewin AA, Heller SL, Jaglan S, et al.

    AJR. American journal of roentgenology 2017; (208(1)):W17-W22 doi:10.2214/AJR.16.16404.

    PMID: 27786559
  3. 3

    Characteristics of a Breast Pathology Consultation Practice.

    East EG, Zhao L, Pang JC, Jorns JM

    Archives of pathology & laboratory medicine 2017; (141(4)):578-584 doi:10.5858/arpa.2016-0371-OA.

    PMID: 28353380
  4. 4

    Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities.

    Ajkay N, Bloomquist EV, Martin RC, et al.

    Surgery 2015; (158(4)):946-52; discussion 952-3.

    PMID: 26283205
  5. 5

    CAR Practice Guidelines on Breast Imaging and Interventions: Breast Intervention and Biopsy Procedures.

    Flegg C, Crivellaro PS, Fienberg S, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2026; 8465371261451254 doi:10.1177/08465371261451254.

    PMID: 42198851
  6. 6

    Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.

    Yincharoen P, Sharma CP, Tawanwongsri W

    Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.

    PMID: 42201021
  7. 7

    MRI in the Assessment of BI-RADS® 4 lesions.

    Leithner D, Wengert G, Helbich T, et al.

    Topics in magnetic resonance imaging : TMRI 2017; (26(5)):191-199 doi:10.1097/RMR.0000000000000138.

    PMID: 28961568
  8. 8

    Assessment of Breast Specimens With or Without Calcifications in Diagnosing Malignant and Atypia for Mammographic Breast Microcalcifications Without Mass: A STARD-Compliant Diagnostic Accuracy Article.

    Cheung YC, Juan YH, Ueng SH, et al.

    Medicine 2015; (94(42)):e1832 doi:10.1097/MD.0000000000001832.

    PMID: 26496323
  9. 9

    Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.

    Prakash S, Venkataraman S, Slanetz PJ, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):122-9.

    PMID: 26632099
  10. 10

    Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.

    Li X, Ma Z, Styblo TM, et al.

    Breast cancer research and treatment 2021; (185(3)):573-581 doi:10.1007/s10549-020-05977-9.

    PMID: 33068196
  11. 11

    American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ.

    Nakhlis F, Bedrosian I, King TA, et al.

    JAMA surgery 2026; (161(10)):1076-1083 doi:10.1001/jamasurg.2026.3552.

    PMID: 42616513
  12. 12

    Spectrum of atypical ductal hyperplasia (ADH) and ductal carcinoma in-situ (DCIS): Diagnostic challenges.

    Bomeisl P, Gilmore H

    Seminars in diagnostic pathology 2024; (41(6)):252-257 doi:10.1053/j.semdp.2024.09.001.

    PMID: 39294011
  13. 13

    Second opinion (external specialist referral) practice of breast pathology: the Nottingham experience.

    Rakha EA, Adebayo LA, Abbas A, et al.

    Histopathology 2023; (83(3)):394-405 doi:10.1111/his.14993.

    PMID: 37356966
  14. 14

    Atypia in breast pathology: what pathologists need to know.

    Katayama A, Toss MS, Parkin M, et al.

    Pathology 2022; (54(1)):20-31 doi:10.1016/j.pathol.2021.09.008.

    PMID: 34872753
  15. 15

    Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists.

    Lee AY, Wisner DJ, Aminololama-Shakeri S, et al.

    Academic radiology 2017; (24(1)):60-66 doi:10.1016/j.acra.2016.09.010.

    PMID: 27793579
  16. 16

    What is the yield of breast MRI in the assessment of palpable breast findings?

    Amitai Y, Menes TS, Weinstein I, et al.

    Clinical radiology 2017; (72(11)):930-935 doi:10.1016/j.crad.2017.06.120.

    PMID: 28754486
  17. 17

    Features of breast cancer initially assessed as probably benign on ultrasound: A retrospective study.

    Ryu HJ, Cha JH, Kim HH, et al.

    Medicine 2022; (101(31)):e29953 doi:10.1097/MD.0000000000029953.

    PMID: 35945803
  18. 18

    Understanding BI-RADS Category 3.

    Fazeli S, Stepenosky J, Guirguis MS, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(1)):e240169 doi:10.1148/rg.240169.

    PMID: 39636752
  19. 19

    Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and Management.

    Weinfurtner RJ, Niell B, Mekhail Y, et al.

    Clinical breast cancer 2018; (18(5)):e1031-e1036 doi:10.1016/j.clbc.2018.03.009.

    PMID: 29625911
  20. 20

    Specialized Second Opinion Review of Breast MRI Impacts Management and Increases Cancer Detection.

    Weinfurtner RJ, Mooney B, Forbus J

    Journal of the American College of Radiology : JACR 2019; (16(7)):922-927 doi:10.1016/j.jacr.2019.01.006.

    PMID: 30833163
  21. 21

    Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer.

    Whorms DS, Giess CS, Golshan M, et al.

    Journal of the American College of Radiology : JACR 2019; (16(6)):814-823 doi:10.1016/j.jacr.2018.10.010.

    PMID: 30579707
  22. 22

    Reducing the Number of Unnecessary Percutaneous Biopsies: The Role of Second Opinion by Expert Breast Center Radiologists.

    Pistolese CA, Lamacchia F, Tosti D, et al.

    Anticancer research 2020; (40(2)):939-950 doi:10.21873/anticanres.14027.

    PMID: 32014938
  23. 23

    Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM.

    Pediconi F, Galati F, Bernardi D, et al.

    La Radiologia medica 2020; (125(10)):926-930 doi:10.1007/s11547-020-01254-3.

    PMID: 32661780
  24. 24

    Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.

    Wharam JF, Zhang F, Lu CY, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018; (36(11)):1121-1127 doi:10.1200/JCO.2017.75.2501.

    PMID: 29489428
  25. 25

    A Review of Breast Imaging for Timely Diagnosis of Disease.

    Bicchierai G, Di Naro F, De Benedetto D, et al.

    International journal of environmental research and public health 2021; (18(11)) doi:10.3390/ijerph18115509.

    PMID: 34063854

This page explains when a second opinion may be useful after a breast fibrosis biopsy or mammogram for informational purposes only. It does not replace advice from your breast-imaging team, pathologist, or other healthcare professional.

Get notified when new evidence is published on breast fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.